Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
| Open | 651.80 | Prev Close | 651.80 |
| High | 651.80 | Low | 651.80 |
| Volume | 0 | Volume (Avg) | 1,069 |
| 52 Week High | 840.91 | 52 Week Low | 475.77 |
| Market Cap | 68.5B | PE Ratio | 15.60 |
General
| Name | Regeneron Pharmaceuticals, Inc |
| Ticker | REGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 15,222 |
About Regeneron Pharmaceuticals, Inc
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Highlights
| Analyst Target | 756.65 |
| Market Cap | 68,492,700,000 |
| PE Ratio | 15.60 |
| PEG Ratio | 1.15 |
| EBITDA | 4,348,000,256 |
Valuation
| Trailing PE | 15.62 |
| Forward PE | 15.46 |
| Price/Sales (Trailing 12 Mt.) | 4.81 |
| Price/Book (Most Recent Quarter) | 2.12 |
Technicals
| Beta | 0.31 |
| 52 Week High | 840.91 |
| 52 Week Low | 475.77 |
| 50 Day Average | 12.00% |
| 200 Day Average | 9.31% |
Dividend
Regeneron Pharmaceuticals, Inc pays out a dividend of $3.08 per share, with a dividend yield of 0.47%.
REGN's next dividend payment will be made to shareholders on December 5, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Dec 5, 2025 | $0.88 |
| Sep 3, 2025 | $0.88 |
| Jun 6, 2025 | $0.88 |
| Mar 20, 2025 | $0.88 |
Elon Musk Tells Joe Rogan: 'Trump Actually Is Not Perfect, but He's Not Evil'
In a Friday appearance on The Joe Rogan Podcast, Elon Musk defended President Donald Trump, stating that while Trump is "not perfect," he is also "not evil."
Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock
Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.
Trump's Radical Plans for the Dollar - Ad
The Fed just slashed rates... yet mortgages have already soared higher. Meanwhile, Trump has his own plan for the dollar - a radical upgrade to our currency, already moving more money than Visa and Mastercard combined. Tech investor Eric Wade calls it the "Smart Dollar."
Gold prices have tumbled from recent records. What's behind the losses?
NEW YORK (AP) — Less than a day after to another record high, prices for the precious metal plunged — marking the biggest sell-off in years.
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
The Wall Street Elites Are Moving Their Money Here - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts
Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.
Trump White House Clamps Down on Press Access
White House restricts reporter access to West Wing Room 140; NSC cites sensitive material, echoing Pentagon curbs, raising press concerns.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
2026 COLA Increase: Social Security Benefits To Rise By 2.8% In 2026, Here's How Much More You Will Get Every Month
The Social Security Administration announced a 2.8% COLA increase for 2026, affecting 75 million Americans.
Move Over, Musk—The World's Richest Woman Joined the $100B Club
Alice Walton, daughter of Walmart founder Sam Walton, is the richest woman in the world worth more than $100 billion.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.
Loggins demands removal of Trump's AI-generated video using ‘Danger Zone’
NEW YORK (AP) — Kenny Loggins is objecting to the use of his music in a social media post showing an artificial intelligence-generated video of dumping excrement from a fighter jet on last weekend's .
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Nvidia, TSMC Unveil The First US-Made Blackwell Wafer, But Analyst Ming-Chi Kuo Flags This Overlooked Detail
Nvidia Corp (NASDAQ: NVDA) has introduced the first U.S.-made Blackwell wafer, a crucial component for AI chips, at Taiwan Semiconductor Manufacturing Co's (NYSE: TSM) facility in Phoenix.
Journalists turn in access badges, exit Pentagon rather than agree to new reporting rules
WASHINGTON (AP) — Dozens of reporters turned in access badges and exited the Pentagon on Wednesday rather than agree to government-imposed , pushing journalists who cover the American military further from the seat of its power. The U.S. government has called the new rules “common sense.”
Elon's Haters Are About to Lose Their Minds... - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
IonQ Shares Are Trading Lower Monday: What's Going On?
IonQ shares were trading higher Monday but have since reversed and began trading lower.
Dogecoin's $0.21 Problem: Why This Analyst Says Keep It On Your Radar
On Monday, social media influencer Ali Martinez, known popularly on X as Ali, drew the attention of the crypto community to an important resistance level for Dogecoin (CRYPTO: DOGE).
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Why Did Dragonfly Energy Shares Jump Over 6% After Hours?
Dragonfly Energy Holdings' stock climbed 6.73% after hours to $1.42 following its public offering and strategic updates.
IonQ, D-Wave Quantum, Rigetti Computing Surge Over 11% Pre-Market: What's Going On?
Shares of IonQ Inc. (NYSE: IONQ), Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum (NYSE: QBTS) surged in premarket trading on Thursday.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Jeff Bezos-Backed Anthropic Projects To Nearly Triple Revenues By 2026: Report
Anthropic, the artificial intelligence (AI) startup, backed by Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) Google and Amazon.com (NASDAQ: AMZN), is reportedly projecting to more than double and potentially nearly triple its annualized revenue run rate next year.
Maye Musk Says She Only 'Lasted' Until 11 PM At Elon's Saturday Meetings, Agrees With Trump's AI Czar No One Works Harder Than Her Son
Maye Musk shares insights into Elon Musk's work habits, emphasizing his dedication. She could only last until 11 PM in his Saturday meetings.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Australian Oilseeds Holdings Shares Soar 248% After Hours Amid Trump Says US Will Make Its Own Cooking Oil
Australian Oilseeds Holdings surged 248% after Trump's trade threat against China sparked a rally in agricultural biotech stocks.
Trump's immigration crackdown weighs heavy on the US labor market
Maria worked cleaning schools in Florida for $13 an hour. Every two weeks, she’d get a $900 paycheck from her employer, a contractor. Not much — but enough to cover rent in the house that she and her 11-year-old son share with five families, plus electricity, a cellphone and groceries.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Tesla, Palantir JPMorgan And More — Here's Why Investors Couldn't Stop Talking About These Stocks This Week
Retail investors buzzed about five stocks this week, from Oct. 13 to Oct. 17 on X and Reddit's r/WallStreetBets: TSLA, RGTI, OKLO, JPM, PLTR
Elizabeth Warren And Adam Schiff Introduce Senate Resolution Condemning Trump's Pardon Of Changpeng Zhao
Senators Elizabeth Warren (D-Mass.) and Adam Schiff (D-CA) are introducing a Senate resolution condemning President Donald Trump‘s pardon of Binance (CRYPTO: BNB) founder
Trump's Radical Plans for the Dollar - Ad
The Fed just slashed rates... yet mortgages have already soared higher. Meanwhile, Trump has his own plan for the dollar - a radical upgrade to our currency, already moving more money than Visa and Mastercard combined. Tech investor Eric Wade calls it the "Smart Dollar."
Netflix, Intuitive Surgical, Beyond Meat, Texas Instruments, Warner Bros: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indexes closed mixed on Tuesday, with the Dow Jones Industrial Average rising nearly 0.5% to 46,924.74.
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.
The Wall Street Elites Are Moving Their Money Here - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, and First Horizon, driven by sector pullbacks, policy concerns on defense buybacks, a high-profile cyber breach, and weak earnings.
AP Business News Digest
Here are the AP's top business stories that have moved or are planned to move today. All times U.S. Eastern. For up-to-the minute information on AP's coverage, visit AP Newsroom’s .
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday?
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.